NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $756,412 | +11.0% | 7,426 | +9.9% | 0.10% | +12.6% |
| Q2 2023 | $681,546 | +41.6% | 6,754 | +29.1% | 0.09% | +31.8% |
| Q1 2023 | $481,160 | +99.2% | 5,230 | +96.5% | 0.07% | +69.2% |
| Q4 2022 | $241,497 | +13.4% | 2,662 | -4.9% | 0.04% | 0.0% |
| Q3 2022 | $213,000 | -29.7% | 2,800 | -21.9% | 0.04% | -29.1% |
| Q2 2022 | $303,000 | +7.8% | 3,587 | +12.0% | 0.06% | +12.2% |
| Q1 2022 | $281,000 | +26.6% | 3,203 | +26.0% | 0.05% | +16.7% |
| Q4 2021 | $222,000 | -7.1% | 2,542 | -12.9% | 0.04% | -23.6% |
| Q3 2021 | $239,000 | -12.1% | 2,919 | -2.0% | 0.06% | -16.7% |
| Q2 2021 | $272,000 | +16.7% | 2,978 | +9.1% | 0.07% | -2.9% |
| Q1 2021 | $233,000 | +2.2% | 2,730 | +13.0% | 0.07% | -12.8% |
| Q4 2020 | $228,000 | +4.6% | 2,416 | -3.4% | 0.08% | -12.4% |
| Q3 2020 | $218,000 | 0.0% | 2,502 | +0.2% | 0.09% | -10.1% |
| Q2 2020 | $218,000 | – | 2,496 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |